Syndax Pharmaceuticals, Inc. (SNDX) Social Stream
SYNDAX PHARMACEUTICALS INC (SNDX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SNDX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-20 | 5 | $37 | $21 | $28 | $22.64 | 23.67% |
| 2022-03-02 | 4 | $37 | $24 | $30.333 | $22.64 | 33.98% |
| 2022-05-10 | 5 | $37 | $24 | $30.5 | $22.64 | 34.72% |
| 2022-05-24 | 4 | $40 | $30 | $33.666 | $22.64 | 48.7% |
| 2022-07-28 | 4 | $40 | $31 | $34 | $22.64 | 50.18% |
| 2022-09-29 | 4 | $35 | $31 | $32.333 | $22.64 | 42.81% |
| 2022-11-04 | 4 | $35 | $31 | $33.333 | $22.64 | 47.23% |
| 2022-12-12 | 4 | $39 | $33 | $35.333 | $22.64 | 56.06% |
| 2023-01-03 | 5 | $41 | $33 | $36.75 | $22.64 | 62.32% |
| 2023-01-31 | 6 | $41 | $33 | $36.8 | $22.64 | 62.54% |
| 2023-03-01 | 6 | $41 | $33 | $35.8 | $22.64 | 58.13% |
| 2023-03-02 | 7 | $41 | $32 | $35.166 | $22.64 | 55.33% |
| 2023-03-07 | 7 | $37 | $32 | $34.333 | $22.64 | 51.65% |
| 2023-03-15 | 7 | $37 | $32 | $34 | $22.64 | 50.18% |
| 2023-05-09 | 8 | $37 | $32 | $34 | $22.64 | 50.18% |
| 2023-05-10 | 8 | $37 | $31 | $34.285 | $22.64 | 51.44% |
| 2023-05-22 | 8 | $37 | $31 | $34 | $22.64 | 50.18% |
| 2023-06-26 | 8 | $37 | $31 | $34.142 | $22.64 | 50.8% |
| 2023-07-11 | 9 | $40 | $31 | $34.875 | $22.64 | 54.04% |
| 2023-07-24 | 9 | $40 | $31 | $35.25 | $22.64 | 55.7% |
| 2023-07-25 | 10 | $42 | $31 | $36.25 | $22.64 | 60.11% |
| 2023-07-26 | 10 | $42 | $31 | $36 | $22.64 | 59.01% |
| 2023-07-27 | 10 | $42 | $34 | $36.333 | $22.64 | 60.48% |
| 2023-08-04 | 9 | $42 | $34 | $36.444 | $22.64 | 60.97% |
| 2023-08-16 | 9 | $42 | $33 | $36.111 | $22.64 | 59.5% |
| 2023-09-05 | 10 | $42 | $34 | $36.75 | $22.64 | 62.32% |
| 2023-10-03 | 10 | $43 | $34 | $37.222 | $22.64 | 64.41% |
| 2023-10-11 | 11 | $43 | $30 | $36.5 | $22.64 | 61.22% |
| 2023-10-18 | 11 | $43 | $30 | $36.7 | $22.64 | 62.1% |
| 2023-10-25 | 12 | $43 | $29 | $36 | $22.64 | 59.01% |
| 2023-11-03 | 12 | $43 | $29 | $35.818 | $22.64 | 58.21% |
| 2023-12-13 | 12 | $43 | $29 | $35.545 | $22.64 | 57% |
| 2023-12-22 | 13 | $45 | $29 | $36.25 | $22.64 | 60.11% |
The Trend in the Analyst Price Target
Over the past 19 months, SNDX's average price target has gone up $2.58.
SNDX reports an average of 97.2% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-07 | 7 | 37 | 32 | 34.333 | 24.23 | 41.7% |
| 2023-05-10 | 8 | 37 | 31 | 34.285 | 20.37 | 68.31% |
| 2023-08-16 | 9 | 42 | 33 | 36.111 | 18.00 | 100.62% |
| 2023-10-03 | 10 | 43 | 34 | 37.222 | 12.64 | 194.48% |
| 2023-10-17 | 11 | 43 | 30 | 36.700 | 12.36 | 196.93% |
SNDX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 13 | 0 | 0 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
Over the past 26 weeks, SNDX's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, SYNDAX PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1049.5% of them.
- In terms of how SYNDAX PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is higher than 3157.49% of that group.
- In the context of stocks in the small market cap category, SYNDAX PHARMACEUTICALS INC's average analyst price target is greater than 3314.08% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SYNDAX PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1487.78% of them.
Stocks similar to SYNDAX PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NEPT, CTMX, and WVE.
View All Top Stocks by Price Target
Is SNDX a Buy, Hold or Sell? See the POWR Ratings now!